Cooper Univ. Hosp. CRS
Camden, New Jersey, United States
Teaching hospital in Camden, New Jersey
1 Cooper Plaza, Camden, NJ 08103
635 Beds
About Cooper Univ. Hosp. CRS
Cooper University Hospital is a teaching hospital and biomedical research facility located in Camden, New Jersey. The hospital formerly served as a clinical campus of Robert Wood Johnson Medical School and the University of Medicine and Dentistry of New Jersey.
There are 635 beds in Cooper Univ. Hosp. CRS.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
10
AIDS Clinical Trials Group
2
Clinical Trials at Cooper Univ. Hosp. CRS
During the past decade, Cooper Univ. Hosp. CRS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Long-Term Outcomes of HIV-Positive Patients
1999-03-01
2006-09-01
Completed
3,669
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
2000-01-01
2013-11-01
Completed
5,982
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
2000-03-01
2008-11-01
Completed
4,150
Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants
2002-01-01
2008-09-01
Completed
883
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
2008-01-01
2013-04-01
Completed
517
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
2008-02-01
2012-11-01
Completed
319
Comparative Study of Three NNRTI-Sparing HAART Regimens
2009-05-01
2013-06-01
Completed
1,814
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Cooper Univ. Hosp. CRS"
#1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "AIDS Clinical Trials Group" with 1 trials as a collaborator and "Adult AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at Cooper Univ. Hosp. CRS
According to Clinical.Site data, the most researched conditions in "Cooper Univ. Hosp. CRS" are
"HIV Infections" (11 trials), "Cardiovascular Diseases" (1 trials), "HIV Infection" (1 trials), "Hepatitis C" (1 trials) and "Herpes Zoster" (1 trials). Many other conditions were trialed in "Cooper Univ. Hosp. CRS" in a lesser frequency.
Clinical Trials Intervention Types at Cooper Univ. Hosp. CRS
Most popular intervention types in "Cooper Univ. Hosp. CRS" are "Drug" (7 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darunavir" (2 trials), "Placebo" (2 trials), "Raltegravir" (2 trials), "Atazanavir" (1 trials) and "Boceprevir (BOC)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cooper Univ. Hosp. CRS
The vast majority of trials in "Cooper Univ. Hosp. CRS" are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Cooper Univ. Hosp. CRS
Currently, there are NaN active trials in "Cooper Univ. Hosp. CRS".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Cooper Univ. Hosp. CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cooper Univ. Hosp. CRS, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".